References
- Adcock IM, Ito K, Barnes PJ. (2004). Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1: 247-54.
- Aitio ML. (2006). N-acetylcysteine - passe-partout or much ado about nothing? Br J Clin Pharmacol 61: 5-15.
- Alvarez B, Radi R. (2001). Peroxynitrite decay in the presence of hydrogen peroxide, mannitol and ethanol: a reappraisal. Free Radic Res 34: 467-75.
- Alvarez B, Radi R. (2003). Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25:: 295-311.
- Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC. (1999). Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130: 963-70.
- Barnes PJ. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148: 245-54.
- Barnes PJ, Ito K, Adcock IM. (2004). Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363: 731-3.
- Beckman JS, Koppenol WH. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-37.
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama 297: 842-57.
- Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364: 1219-28.
- Black PN, Morgan-Day A, McMillan TE, Poole PJ, Young RP. (2004). Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med 4: 13.
- Boman G, Backer U, Larsson S, Melander B, Wahlander L. (1983). Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64: 405-15.
- Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51-8.
- Campbell KJ, Rocha S, Perkins ND. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-65.
- Ceriello A. (2006). Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 17: 510-8.
- Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. (1998). Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31.
- Chen LF, Greene WC. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81: 549-57.
- Chien YH, Bau DT, Jan KY. (2004). Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair. Free Radic Biol Med 36: 1011-7.
- Cooke CL, Davidge ST. (2002). Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282: C395-402.
- Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. (1999). Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1635-9.
- Dai Y, Rahmani M, Grant S. (2003). An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cells. Cell Cycle 2: 467-72.
- de Grey AD. (2006). Free radicals in aging: causal complexity and its biomedical implications. Free Radic Res 40: 1244-9.
- de la Lastra CA, Villegas I, Sanchez-Fidalgo S. (2007). Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications. Curr Pharm Des 13: 933-62.
- Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W et al.. (2005). Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365: 1552-60.
- Dedon PC, Tannenbaum SR. (2004). Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423: 12-22.
- Demicheli V, Quijano C, Alvarez B, Radi R. (2007). Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide. Free Radic Biol Med 42: 1359-68.
- Forstermann U, Munzel T. (2006). Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-14.
- Gallou-Kabani C, Junien C. (2005). Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes 54: 1899-906.
- Graham B, Gibson SB. (2005). The two faces of NFkappaB in cell survival responses. Cell Cycle 4: 1342-5.
- Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A. (2003). Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 35: 140-8.
- Harman D. (2003). The free radical theory of aging. Antioxid Redox Signal 5: 557-61.
- Harman D. (2006). Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 1067: 10-21.
- Herbert V. (1994). The antioxidant supplement myth. Am J Clin Nutr 60: 157-8.
- Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO et al.. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-53.
- Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. (2004). Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315: 240-5.
- Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC et al.. (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-76.
- Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. (2001). Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. Faseb J 15: 1110-2.
- Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ and Adcock IM. (2006). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203: 7-13.
- Jiang YH, Bressler J, Beaud et al.. (2004). Epigenetics and human disease. Annu Rev Genomics Hum Genet 5: 479-510.
- Joshi MS, Ferguson TB Jr, Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR Jr. (2002). Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A 99: 10341-6.
- Juedes MJ, Wogan GN. (1996). Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat Res 349: 51-61.
- Kiningham KK, Xu Y, Daosukho C, Popova B, St Clair DK. (2001). Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem J 353: 147-156.
- Kirkham P, Rahman I. (2006). Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 111: 476-94.
- Korkmaz A, Kurt B, Yildirim I, Basal S, Topal T, Sadir S, Oter S. (2008a). Effects of Poly(ADP-Ribose) Polymerase Inhibition in Bladder Damage Caused by Cyclophosphamide in Rats. Exp Biol Med (Maywood) 233: 338-43.
- Korkmaz A, Oter S, Sadir S, Coskun O, Topal T, Ozler M, Bilgic H. (2005). Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol 173: 1793-6.
- Korkmaz A, Topal T, Oter S. (2007). Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23: 303-12.
- Korkmaz A, Topal T, Oter S, Tan DX, Reiter RJ. (2008b). Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. Mini Rev Med Chem 8: 1144-53.
- Korkmaz A, Yaren H, Topal T, Oter S. (2006). Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 80: 662-70.
- Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF. (2007). Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 99: 754-64.
- Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, Waeber B, Liaudet L. (2006). Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 41: 886-95.
- Linnane AW, Kios M, Vitetta L. (2007). The essential requirement for superoxide radical and nitric oxide formation for normal physiological function and healthy aging. Mitochondrion 7: 1-5.
- Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC. (2002). Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25: 1919-27.
- Loppow D, Schleiss MB, Kanniess F, Taube C, Jorres RA, Magnussen H. (2001). In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 95: 115-21.
- Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31: 633-42.
- Masuda M, Nishino H, Ohshima H. (2002). Formation of 8-nitroguanosine in cellular RNA as a biomarker of exposure to reactive nitrogen species. Chem Biol Interact 139: 187-97.
- Mattson MP, Culmsee C, Yu Z, Camandola S. (2000). Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem 74: 443-56.
- McLachlan JA. (2001). Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22: 319-41.
- McLachlan JA, Burow M, Chiang TC, Li SF. (2001). Gene imprinting in developmental toxicology: a possible interface between physiology and pathology. Toxicol Lett 120: 161-4.
- Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. (2005). Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46.
- Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. (2007). Cancer genetics of epigenetic genes. Hum Mol Genet 16 Spec No 1: R28-49.
- Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. (2005). Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-52.
- Moncada S, Palmer RM, Higgs EA. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-42.
- Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, Bauter MR, Kilty I, Rahman I. (2004). Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. Faseb J 18: 1897-9.
- Moretti M, Marchioni CF. (2007). An overview of erdosteine antioxidant activity in experimental research. Pharmacol Res 55: 249-54.
- Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, Holownia A. (2007). Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 58 Suppl 5: 453-60.
- Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. (2002). Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 162: 1472-6.
- Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. (2001). Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276: 29596-602.
- Pacher P, Beckman JS, Liaudet L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424.
- Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM. (1999). N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration 66: 495-500.
- Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523-7.
- Poli G, Parola M. (1997). Oxidative damage and fibrogenesis. Free Radic Biol Med 22: 287-305.
- Rahman I, MacNee W. (1996). Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 51: 348-50.
- Rahman I, Marwick J, Kirkham P. (2004). Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68: 1255-67.
- Rasmussen JB, Glennow C. (1988). Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur Respir J 1: 351-5.
- Riccioni G, Barbara M, Bucciarelli T, di Ilio C, D'Orazio N. (2007). Antioxidant vitamin supplementation in asthma. Ann Clin Lab Sci 37: 96-101.
- Roy S, Packman K, Jeffrey R, Tenniswood M. (2005). Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ 12: 482-91.
- Salganik RI. (2001). The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20: 464S-472S; discussion 473S-475S.
- Slatore CG, Littman AJ, Au DH, Satia JA, White E. (2008). Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 177: 524-30.
- Song YS, Lee YS, Chan PH. (2005). Oxidative stress transiently decreases the IKK complex (IKK alpha, beta, and gamma), an upstream component of NF-kappaB signaling, after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25: 1301-11.
- Song YS, Lee YS, Narasimhan P, Chan PH. (2007). Reduced oxidative stress promotes NF-kappaB-mediated neuroprotective gene expression after transient focal cerebral ischemia: lymphocytotrophic cytokines and antiapoptotic factors. J Cereb Blood Flow Metab 27: 764-75.
- Stockklauser-Farber K, Ballhausen T, Laufer A, Rosen P. (2000). Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta 1535: 10-20.
- Sun Y, Oberley LW. (1996). Redox regulation of transcriptional activators. Free Radic Biol Med 21: 335-48.
- Szabo C. (2003). Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141: 105-12.
- Szabo C. (2006). Poly(ADP-ribose) polymerase activation by reactive nitrogen species-relevance for the pathogenesis of inflammation. Nitric Oxide 14: 169-79.
- Tamir S, deRojas-Walker T, Wishnok JS, Tannenbaum SR. (1996). DNA damage and genotoxicity by nitric oxide. Methods Enzymol 269: 230-43.
- Virag L, Szabo E, Gergely P, Szabo C. (2003). Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 140-141: 113-24.
- Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361: 2017-23.
- Wallaert B, Lassalle P, Fortin F, Aerts C, Bart F, Fournier E, Voisin C. (1990). Superoxide anion generation by alveolar inflammatory cells in simple pneumoconiosis and in progressive massive fibrosis of nonsmoking coal workers. Am Rev Respir Dis 141: 129-33.
- Wang T, Zhang X, Li JJ. (2002). The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2: 1509-20.
- Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM. (2007). The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25: 227-34.
- Weidig P, McMaster D, Bayraktutan U. (2004). High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab 6: 432-41.
- Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. (1998). Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A 95: 5246-50.
- Woo JJ. (2007). Adverse event monitoring and multivitamin-multimineral dietary supplements. Am J Clin Nutr 85: 323S-324S.
- Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H. (2001). Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn J Cancer Res 92: 439-51.
- Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, St Clair DK. (1999). An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 18: 709-22.
- Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T, Karayilanoglu T. (2007). Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 83: 116-22.
- Yermilov V, Yoshie Y, Rubio J, Ohshima H. (1996). Effects of carbon dioxide/bicarbonate on induction of DNA single-strand breaks and formation of 8-nitroguanine, 8-oxoguanine and base-propenal mediated by peroxynitrite. FEBS Lett 399: 67-70.
- Yoshie Y, Ohshima H. (1997). Nitric oxide synergistically enhances DNA strand breakage induced by polyhydroxyaromatic compounds, but inhibits that induced by the Fenton reaction. Arch Biochem Biophys 342: 13-21.